Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > BUSINESS
BUSINESS
- Shire Names NBI Operating Officer Sunohara as New Japan Head
December 20, 2013
- Bristol to Sell Global Diabetes Biz to AstraZeneca; Deal Covers SGLT-2 Asset Transfer
December 20, 2013
- Can Epadel Continue to Maintain Sales in the Face of Competition from Lotriga and Generics?
December 20, 2013
- UMN, API, Yakult Conclude Another Joint Biosimilar Business Agreement in Oncology Field
December 19, 2013
- Astellas, Nichi-Iko Conclude Definitive Agreement on Transfer of Fuji Plant
December 19, 2013
- ViiV Healthcare, Shionogi Seal Copromotion Deal for Anti-HIV Treatment Dolutegravir
December 18, 2013
- Hyperlipidemia Treatment PCSK9 Inhibitors May Be Launched in Japan in 2016
December 17, 2013
- Ono Forms Subsidiary in S. Korea, Sets Sights on Anticancer Drug Sales
December 17, 2013
- AstraZeneca Japan to Draw on Overseas Dapagliflozin Data to Trump SGLT-2 Rivals
December 16, 2013
- Pfizer Japan to Reorganize in January with Stand-Alone Vaccines Unit
December 16, 2013
- Medipal to Venture into Contract PMS Business, Making Medi-Skette Its Wholly Owned Subsidiary
December 16, 2013
- AstraZeneca Japan Sees Annual Growth of Around 8%, Eyes Addition of 160 Reps
December 13, 2013
- Kyowa Kirin, Hisamitsu Launch Cancer Pain Treatment Abstral Sublingual Tablets
December 13, 2013
- IPSN Proposes Life Sciences Business Platform in Tokyo to Be Included in Mr Abe’s Special Zones
December 12, 2013
- Mochida Buys Back 100,000 Shares
December 12, 2013
- New Osaka Logistics Center to Go Live in January: Taisho
December 12, 2013
- Otsuka, Lundbeck to Codevelop Vaccine for Alzheimer’s Disease
December 12, 2013
- US FDA Advisory Panel Backs Takeda Ulcerative Colitis Drug
December 11, 2013
- Santen Sets Up Local Subsidiary in Singapore
December 11, 2013
- Takeda to Establish New CIO Post, Appoint Former Nestlé Exec
December 11, 2013
ページ
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…